| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |